BLFS - Kapitalisasi pasar BioLife Solutions Inc

Logo perusahaan publik biolifesolutions.com (BLFS)

BioLife Solutions, Inc. (BLFS) relies on the integration of its solutions into FDA regulations, which guarantees absolute loyalty from B2B partners. The business also develops specialized containers and media for the secure delivery of biomaterials, maintaining logistics profitability. The recruitment of rare cryopreservation experts drives technological growth, and the market capitalization stands at 1.88. This chart illustrating the price evolution of the quotes below confirms the company's market dynamics.

BLFS biolifesolutions.com: Kapitalisasi pasar ing interval 04.07.2022 - 18.10.2026

BioLife - rincian analitis lan metrik utama (BLFS)

Indikator keuangan lan pasar perusahaan BioLife Solutions, Inc. (BLFS):
Analisis fundamental perusahaan:BioLife Solutions BLFS
Produk asli BioLife

Market capitalization represents the aggregate value of all an issuer's shares, reflecting the current market consensus regarding the business's fundamental value. By analyzing the capitalization dynamics of BioLife Solutions, Inc. (BLFS), an investor identifies trend reversal points, assessing how the market re-evaluates the value of BioLife Solutions, Inc. (BLFS) ESG integration into the production of energy-efficient cryopreservation systems and eco-friendly packaging solutions for cell therapy.

Karo sapa BioLife Solutions, Inc. saingan

Nilai pasar Tempus TEM|Qiagen NV - Nilai pasar|Ionis Pharma - Kapitalisasi pasar|Biji pasar RGEN|Avidity Biosciences (RNA) - Nilai pasar|CRSP - Kapitalisasi pasar|WGS (GeneDx) - Kapitalisasi pasar|Kapitalisasi pasar RARE (Ultragenyx Pharmaceutical Inc.)|Nilai pasar Beam Therapeutics Corp (BEAM)|Sarepta Corp - Kapitalisasi pasar|Kapitalisasi pasar TWST (Twist Bioscience)|Kapitalisasi pasar 10xgenomics.com TXG|Intellia Therapeutics, Inc. - Kapitalisasi pasar|STOK: Nilai pasar|WVE: Kapitalisasi pasar|MAZE - Kapitalisasi pasar|Nilai pasar Sionna Therapeutics Inc|Nilai pasar primemedicine.com PRME|Nilai pasar Taysha Gene Therapies, Inc. (TSHA)|Nilai pasar QURE (uniQure NV)|Kapitalisasi pasar MGTX (MeiraGTx PLC)|Kapitalisasi pasar REGENXBIO Corp (RGNX)|Solid Biosciences Inc. - Kapitalisasi pasar|Biji pasar OCGN|PACB: Kapitalisasi pasar|Nilai pasar Benitec Biopharma Inc (BNTC)|Biji pasar DSGN|RCKT: Nilai pasar|Nilai pasar 4D Molecular Therapeutics (FDMT)|Kapitalisasi pasar lexeotx.com|Nilai pasar Korro Bio KRRO|Editas Medicine Inc (EDIT) - Nilai pasar|SLN - Nilai pasar|PRQR: Nilai pasar|CDXS (codexis.com) - Biji pasar|sangamo.com (SGMO) - Kapitalisasi pasar|Biji pasar NAUT|MGX (Metagenomi Inc.) - Nilai pasar|Kapitalisasi pasar DTIL|Kapitalisasi pasar generationbio.com|Nilai pasar Boundless Bio, Inc. BOLD|Exicure Inc. (XCUR) - Nilai pasar|IMNN - Nilai pasar|PHIO (Phio Pharmaceuticals) - Kapitalisasi pasar|mustangbio.com (MBIO) - Nilai pasar|RNAZ - Kapitalisasi pasar|Biji pasar BNGO|APDN: Nilai pasar|Kapitalisasi pasar BLUE|Kapitalisasi pasar immunoprecise.com|Nilai pasar Omega OMGA|OMIC: Kapitalisasi pasar|Regulus Therapeutics - Kapitalisasi pasar|syros.com (SYRS) - Biji pasar|TBIO (Telesis Bio) - Biji pasar|TCON - Kapitalisasi pasar|UBX (Unity Bio) - Kapitalisasi pasar